Powder: -20°C for 3 years | In solvent: -80°C for 1 year
GS-6201 (CVT-6883) is a selective antagonist of adenosine A2B receptor. GS-6201 shows high affinity and selectivity for the human adenosine A2B receptors with a Ki of 22 nM.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 37.00 | |
5 mg | In stock | $ 96.00 | |
10 mg | In stock | $ 155.00 | |
25 mg | In stock | $ 328.00 | |
50 mg | In stock | $ 522.00 | |
100 mg | In stock | $ 759.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 117.00 |
Description | GS-6201 (CVT-6883) is a selective antagonist of adenosine A2B receptor. GS-6201 shows high affinity and selectivity for the human adenosine A2B receptors with a Ki of 22 nM. |
Targets&IC50 | A2B:22 nM(Ki, human), A3:1070 nM(Ki, human), A1:1940 nM(Ki, human), A2A:3280 nM(Ki, human) |
In vivo | GS-6201 (2 mg/kg; p.o.) treatment displays the Cmax, dAUC and t1/2 are 1110 ng/mL, 6500 ng h/mL, and 4.25 hours, respectively [1]. GS-6201 (4 mg/kg; i.p.; every 12 h for 14 days) obviously decreases IL-6, TNF-α, E-selectin, ICAM-1, and VCAM plasma levels. GS-6201 (4 mg/kg; i.p.; every 12 h for 14 days) causes an obvious attenuation of left and right ventricular enlargement and dysfunction at 7 days, which was maintained at 14 days and also at 28 days [2]. |
Synonyms | CVT-6883 |
Molecular Weight | 446.43 |
Formula | C21H21F3N6O2 |
CAS No. | 752222-83-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 30 mg/ml (67.2 mM), Sonication and heating to 60℃ are recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
GS-6201 752222-83-6 GPCR/G Protein Neuroscience Adenosine Receptor GS 6201 GS6201 Inhibitor remodeling cardiac caspase-1 reactivity airway affinity infarction P1 receptor CVT-6883 inhibit CVT6883 acute CVT 6883 selectivity myocardial inhibitor